Xin Zhou is an experienced professional in the field of life sciences, currently serving as a Director at Neurocrine Biosciences and previously at Eli Lilly and Company. The career includes roles as Principal Research Scientist and Senior Research Scientist at Eli Lilly and Company, alongside acting as Co-Chair for the Human PK Prediction IQ Working Group. Prior experience includes a Postdoctoral Scientist position at Pfizer and a Research Affiliate role at the Wadsworth Center, NYS Department of Health.